Chris Urch
I did my first degree at Cambridge reading natural sciences and chemistry. I stayed at Cambridge to complete my PhD on organic synthesis with Professor Ian Fleming and then moved to the United States to undertake post-doctoral research, again on organic synthesis, with Professor Barry Trost. On returning to this country I started work for ICI Agrochemicals where I remained for 16 years as it became Zeneca and eventually Syngenta. During this time, I worked on both fungicide and insecticide research, principally sterol biosynthesis inhibitors and acetylcholine receptor agonists respectively.
After leaving Syngenta I joined Amura, a start-up company in Cambridge. Amura was developing antibiotics and in particular a β-lactamase inhibitor. I stayed with Amura for three years and then joined Glycoform for six years, a spin-out from the University of Oxford, where I was the Research Director. Glycoform researched various ways of improving pharmaceuticals by the use of sugars.
After leaving Glycoform I worked as a consultant, increasingly for Redag Crop Protection who are researching novel agrochemicals. Four years ago, I joined them full time as Head of Chemistry.
Jonathan Statham
Kevin Purdy
Paulo Bosi
Andrew Skidmore
Philipp Schulte
Philipp has spent the past 15 years working across the Life Sciences where he got a first-row view on the changing paradigms and new technologies that will turn the 21st century into the age of biology. He is currently CEO of Baze (a Nature's Way company) which he co-founded in 2014 with the mission to pioneer convenient and effective personalized nutrition.
Wade H. Elmer
David Beaudreau
